AU Stock MarketDetailed Quotes

CMB Cambium Bio Ltd

Watchlist
  • 0.006
  • 0.0000.00%
20min DelayMarket Closed Jun 14 14:53 AET
3.68MMarket Cap-1000P/E (Static)

About Cambium Bio Ltd Company

Cambium Bio Ltd, formerly Regeneus Ltd is a clinical-stage regenerative medicine company in Australia. The company develops a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology, and dermatology diseases. The company uses stem cell and immuno-oncology technologies to develop cell-based therapies. The company's product pipeline consists of two platform technologies, Progenza and Sygenus, across three target therapeutic areas namely osteoarthritis, neuropathic pain, and skin wound healing.

Company Profile

SymbolCMB
Company NameCambium Bio Ltd
Founded2007
MarketASX
Fiscal Year Ends06-30
Address16 Goodhope Street Paddington
CitySydney
CountryAustralia
Zip Code2021
Phone+61 1300995098

Company Executives

  • Name
  • Position
  • Salary
  • Graham Vesey
  • Chief Scientific Officer,Executive Director
  • --
  • Barry George Sechos
  • Non-Executive Director,Non-Executive Chairman
  • --
  • Leo Lee
  • Non-Executive Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg